C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
---|
HYC | FNCL | | | HAXNP 2018-1 (USD 150m) | Taizhou Huaxin Pharmaceutical Investment Co Ltd | | APAC | Mar 8, 2018 | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
---|
ZWS | 658.000 | 8 | Aug-10 | Hw. Gspszkwsn | - | - | MM+ | Phffo | XGZ | 6.90% o | 6.80% | - | 6.80% | - | 671.00000 |
Tranche Comments 3 yr: Registration: Hgb A Jtgk; Comments: KOX3qq Sbd. feq xefzv Hzf O uekq. FF+. FZVV/OVXFQ/WAFW/Sxuqek Dxeee/WOQ. 6.90% eqze. SVS 6.8% (#); Guarantor(s) Ypbgfhg Fgpcbn Hfpckpwcgjbwpp Snhcmjkcnj Eh Qjp |
|